INTERNATIONAL PATENT: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK FILES APPLICATION FOR "EX VIVO GENERATED ANTIGEN-SPECIFIC CD4+ T CELLS WITH ENHANCED SELF-RENEWAL AND CYTOTOXIC ACTIVITY FOR IMMUNOTHERAPY OF CANCER"

GENEVA, May 12 -- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (412 Low Memorial Library535 W. 116th StreetNew York, NY 10027) filed a patent application (PCT/US2025/052773) for "EX VIVO GENERATED ANTIGEN-SPECIFIC CD4+ T CELLS WITH ENHANCED SELF-RENEWAL AND CYTOTOXIC ACTIVITY FOR IMMUNOTHERAPY OF CANCER" on Oct 28, 2025. With publication no. WO/2026/096415, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MURANSKI, Pawel (161 Fort Washington Ave., Hip Garden LevelNew York, NY 10032), SONI, Mithil (21 Lincoln...